Rhinocort vs Eltair: a comparative review of a patented and generic drug.
Rhinocort and Eltair are both the patented and generic equivalent of the topical nasal steroid budesonide. A study consisting of 42 patients was conducted at the ENT department of Hospital Ipoh to compare the response of patients who were using Rhinocort prior to Eltair. The results show statistically significant symptomatic response and lower complications with Rhinocort compared to Eltair.
Gurdeep
S M
SM
Department of ENT (Ear, Nose and Throat), Hospital Ipoh,30990 Ipoh, Perak.
Philip
R
R
Rosalind
S
S
D000281:Administration, Intranasal; D019819:Budesonide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016568:Drugs, Generic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D016896:Treatment Outcome
D016568:Drugs, Generic; D005938:Glucocorticoids; D019819:Budesonide